CovidVax show full list
COVID-19 VACCINE:

DNA

researcher:
Entos Pharma + Cytiva
https://www.entospharma.com/
https://www.cytivalifesciences.com/en/us
(Canada + USA)
vaccine type: DNA-based
Distribution updates
currently no distribution info
Human Testing updates (clinical trials)

PHASE 1

 

started December 1 2020

with 72 healthy volunteers aged 18-84

» clinical trial details

Animal Testing updates (pre-clinical trials)
currently no pre-clinical trials info
early development updates
May 25Entos today announced the selection of two lead candidates for its program launched at the onset of the global pandemic (by entospharma.com)
Mar 18Entos Pharmaceutical announced their development of a vaccine (by businesswire.com)



funding:
Canadian Institute of Health Research (CIHR) + Research Nova Scotia (RNS) + Institute for Ageing (IA) $4.2M + National Research Council of Canada Industrial Research Assistance Program (NRC IRAP) $5M
Oct 23Entos was awarded up to $5M in NRC IRAP funding to conduct Phase 1 clinical trial of its vaccine (by entospharma.com)
Jun 25Entos was granted a $4.2M from various canadian institutions to further develop its vaccine (by businesswire.com)
partnerships:
Jun 01Entos Pharmaceutical and Cytiva will work together to accelerate development of a vaccine (by cytivalifesciences.com)



contact | about | ©2020 CovidVax.org project